Drugs Made In America Acquisition Corp. | SPAC Research

Drugs Made In America Acquisition Corp.

Status: Pre-Deal

U=S+R R=S/8

IPO Proceeds, $M	$230.00M
IPO Date	Jan 28, 2025
CEO	Lynn Stockwell
Left Lead	Clear Street
IPO Cash in Trust	100.5%
SPAC Tenor	15+(2*3)
IPO Sector	Healthcare ▶
IPO Geography	Global
Target Company	TBD
Deal Announced	TBD
Deal Size, $M	TBD
Deal Sector	TBD
Deal Geography	TBD
SEC Filings	www.sec.gov
Approval Vote	TBD
Amendment Vote	TBD

DMAA DMAAU DMAAR

Price	$10.27
Last closing price	$10.32
H/L, today	$10.30 / $10.31
Volume, today	6,137
Volume, 3-month avg.	N/A

Price	$10.48
Last closing price	$10.49
High/low price, today	$10.48 / $10.48
Volume, today	2,692
Volume, 3-month avg.	N/A

Price
Volume, today
Volume, 3-month avg.	N/A

Price	$0.18
Last closing price	$0.18
High/low price, today	$0.17 / $0.19
Volume, today	8,089
Volume, 3-month avg.	N/A

Sign up for Free Trial

No credit card required

Sign in to view structure, cap table, and calendar of events.